RDW underwent a massive balance sheet transformation with assets growing 395% and equity swinging from -$189M to $1.1B, but operating losses widened dramatically to -$230M.
The company appears to have completed a major capital raise or acquisition that eliminated negative equity and massively expanded its asset base, as evidenced by the 154% increase in share count and inventory surge. However, the 444% increase in operating losses and 922% deterioration in operating cash flow indicate serious operational challenges accompanying this growth.
RDW's financials reflect a dramatic expansion story with mixed results - while the balance sheet strengthened enormously through what appears to be significant capital infusion (assets up 395%, equity from negative to $1.1B), operational performance deteriorated severely with operating losses expanding to -$230M and operating cash flow bleeding -$177M. The massive inventory build-up (+2,394%) and doubling of SG&A expenses suggest either major acquisitions or aggressive scaling efforts that have not yet translated to profitability. This represents a company in major transition with substantial new resources but unproven ability to deploy them effectively.
Inventory surged 2394.3% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Operating cash flow fell 922.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Equity base grew 661.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Asset base grew 395.2% — expansion through organic growth, acquisitions, or capital deployment.
R&D investment increased 222.5% — signals commitment to future product development, though near-term margin impact.
Cash position surged 180.2% — strong cash generation or capital raise providing significant financial cushion.
SG&A up 139.9% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Capital expenditure jumped 110.6% — major investment cycle underway; assess returns on deployment.
Current assets grew 100.8% — improving short-term liquidity or inventory/receivables build.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →